Global Next Generation Sequencing (NGS) Market- Industry Analysis, Share, Size, Growth, Trends, Opportunity and Forecast 2022-2030
Categories: Life Science
Formate : 
Global Next Generation Sequencing (NGS) Market was valued at USD XX Billion in the year 2021. Global Next Generation Sequencing (NGS) Market is further estimated to grow at a CAGR of XX% from 2022 to 2030 it will reach USD XX Billion by the year 2030. The North America region holds the highest market share in 2021 and the Asia Pacific is considered as the fastest growing market in the forecasted period. At a country level, US, China are projected to grow strongly in the coming years due to increasing density of population and funding through Research and Development.
The Global Next Generation Sequencing (NGS) Report 2022-2030 covers market opportunities and challenges, key market regulations’ information, analysis of new products from the market players and key market trends, market share analysis for key players, supply chain and value chain analysis, product and Material trends, pricing analysis, emerging applications, technologies and major recent developments. This information has also been provided for the major country markets in these regions. Market shares, size and growth potential are assessed for these major country markets. Market opportunities, challenges, government regulations, market share analysis by major competitors, recent major market developments (product launches, M&A, partnerships, etc.) and other information have been covered for the major country markets listed in this section.
On the basis of Type, the market is divided as Instruments, Consumables and Services. In which Instruments for the largest market share due to increasing demand in future market trends. Regional breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and ROW.
Market player analysis of major companies such as Agilent Technologies, Inc., BGI Group, F. Hoffmann-La Roche AG, Illumina Inc, Precigen Inc., (Intrexon Bioinformatics Germany GmbH), Pacific Biosciences of California, Inc., PerkinElmer, Inc., PierianDx Inc., Qiagen N.V., and Thermo Fisher Scientific Inc…
![]()
The Global Next Generation Sequencing (NGS) Report 2022-2030 covers market opportunities and challenges, key market regulations’ information, analysis of new products from the market players and key market trends, market share analysis for key players, supply chain and value chain analysis, product and Material trends, pricing analysis, emerging applications, technologies and major recent developments. This information has also been provided for the major country markets in these regions. Market shares, size and growth potential are assessed for these major country markets. Market opportunities, challenges, government regulations, market share analysis by major competitors, recent major market developments (product launches, M&A, partnerships, etc.) and other information have been covered for the major country markets listed in this section.
On the basis of Type, the market is divided as Instruments, Consumables and Services. In which Instruments for the largest market share due to increasing demand in future market trends. Regional breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and ROW.
Market player analysis of major companies such as Agilent Technologies, Inc., BGI Group, F. Hoffmann-La Roche AG, Illumina Inc, Precigen Inc., (Intrexon Bioinformatics Germany GmbH), Pacific Biosciences of California, Inc., PerkinElmer, Inc., PierianDx Inc., Qiagen N.V., and Thermo Fisher Scientific Inc…
| Particular | Scope |
|---|---|
| Region |
|
| Historic Year | 2016-2020 |
| Base Year | 2021 |
| Forecast Year | 2022 - 2030 |
| Quantitative units | Revenue in USD million/billion and CAGR from 2022 to 2030 |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | Component, technology, type, application, region |
This research report will answer the following questions:
- Which are the major players and what are their business plans on a global scale?
- Which are the major industry regions?
- Growth opportunities and trend analysis?
- Competition strategy and market share analysis?
1 INTRODUCTION
1.1 OBJECTIVES
1.2 RESEARCH METHODOLOGY
1.2.1 SECONDARY DATA
1.2.2 PRIMARY DATA
1.2.3 MARKET SIZE ESTIMATION
1.2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
1.3 STAKEHOLDERS
1.4 RESEARCH ASSUMPTIONS
1.5 LIMITATION
2 EXECUTIVE SUMMARY
3 MARKET OUTLOOK
3.1 INTRODUCTION
3.2 OPPORTUNITIES MATRIX
3.3 MARKET CHALLENGES
3.4 MARKET SHARE ANALYSIS
3.5 VALUE CHAIN ANALYSIS
3.6 DEMAND SIDE ANALYSIS
3.7 SUPPLY SIDE ANALYSIS
3.8 PORTER’S FIVE FORCES MODEL
3.8.1 DEGREE OF COMPETITION
3.8.2 BARGAINING POWER OF BUYERS
3.8.3 BARGAINING POWER OF SUPPLIERS
3.8.4 THREAT FROM SUBSTITUTES
3.8.5 THREAT FROM NEW ENTRANTS
4 INDUSTRY TRENDS
4.1 PRODUCT LIFE CYCLE
4.2 NEW MARKET ENTRY STRATEGY
4.3 PESTEL ANALYSIS
4.4 PRICING ANALYSIS
4.5 TRADE DATA
4.6 TECHNOLOGICAL OVERVIEW
4.7 FUTURE OUTLOOK MARKET TRENDS
4.8 MACRO-ECONOMIC VARIABLES (DEPENDENT AND INDEPENDENT VARIABLES)
4.9 MULTIFACTOR BASED SENSITIVITY ANALYSIS
4.10 REGRESSION MATRIX
4.11 COVID-19 IMPACT ANALYSES
4.12 GE MATRIX
5 NEXT GENERATION SEQUENCING (NGS) TYPE ANALYSIS
5.1 INTRODUCTION
5.2 HISTORICAL MARKET TYPE ANALYSIS, 2016-2020
5.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
5.4 Y-O-Y GROWTH TREND ANALYSIS
5.5 INSTRUMENTS
5.6 CONSUMABLES
5.6.1 SAMPLE PREPARATION CONSUMABLES
5.6.1.1 DNA Fragmentation, End Repair, A-Tailing and Size Selection
5.6.1.2 Library Preparation & Target Enrichment
5.6.1.3 Quality Control
5.6.2 OTHER CONSUMABLES
5.6.2.1 Platforms
5.6.2.2 HiSeq
5.6.2.3 MiSeq
5.6.2.4 Ion Torrent
5.6.2.5 SOLiD
5.6.2.6 Pacbio Rs II and Sequel System
5.6.2.7 Other Sequencing Platforms
5.7 SERVICES
5.7.1 SEQUENCING SERVICES
5.7.1.1 RNA Sequencing
5.7.1.2 Whole Exome Sequencing
5.7.1.3 Whole Genome Sequencing
5.7.1.4 Targeted Sequencing
5.7.1.5 Chip Sequencing
5.7.1.6 De Novo Sequencing
5.7.1.7 Methyl Sequencing
5.7.2 DATA MANAGEMENT SERVICES
5.7.2.1 NGS Data Analysis Services
5.7.2.2 NGS Data Analysis Software & Workbenches
5.7.2.3 NGS Storage, Management and Cloud Computing Solutions
6 NEXT GENERATION SEQUENCING (NGS) TYPE OF SEQUENCING ANALYSIS
6.1 INTRODUCTION
6.2 HISTORICAL MARKET TYPE OF SEQUENCING ANALYSIS, 2016-2020
6.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
6.4 Y-O-Y GROWTH TREND ANALYSIS
6.5 WHOLE GENOME SEQUENCING
6.6 TARGETED RESEQUENCING
6.7 WHOLE EXOME SEQUENCING
6.8 RNA SEQUENCING
6.9 CHIP SEQUENCING
6.10 DE NOVO SEQUENCING
6.11 METHYL SEQUENCING
7 NEXT GENERATION SEQUENCING (NGS) TECHNOLOGY ANALYSIS
7.1 INTRODUCTION
7.2 HISTORICAL MARKET TECHNOLOGY ANALYSIS, 2016-2020
7.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
7.4 Y-O-Y GROWTH TREND ANALYSIS
7.5 SEQUENCING BY SYNTHESIS
7.6 ION SEMICONDUCTOR SEQUENCING
7.7 SEQUENCING BY LIGATION
7.8 PYROSEQUENCING
7.9 SINGLE MOLECULE REAL TIME SEQUENCING
7.10 OTHER TECHNOLOGIES
8 NEXT GENERATION SEQUENCING (NGS) END USER ANALYSIS
8.1 INTRODUCTION
8.2 HISTORICAL MARKET END USER ANALYSIS, 2016-2020
8.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
8.4 Y-O-Y GROWTH TREND ANALYSIS
8.5 ACADEMIC AND RESEARCH CENTERS
8.6 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
8.7 HOSPITALS AND CLINICS
8.8 OTHER END USERS
9 NEXT GENERATION SEQUENCING (NGS) MARKET APPLICATION ANALYSIS
9.1 INTRODUCTION
9.2 HISTORICAL MARKET APPLICATION ANALYSIS, 2016-2020
9.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
9.4 Y-O-Y GROWTH TREND ANALYSIS
9.5 DIAGNOSTICS
9.6 BIOMARKERS AND CANCER
9.7 REPRODUCTIVE HEALTH
9.8 PERSONALIZED MEDICINE
9.9 AGRICULTURE AND ANIMAL RESEARCH
9.10 OTHER APPLICATIONS
10 GLOBAL NEXT GENERATION SEQUENCING (NGS) REGIONAL ANALYSIS
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 NORTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.2.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
10.2.3 Y-O-Y GROWTH TREND ANALYSIS
10.2.3.1 U.S.
10.2.3.2 Canada
10.2.3.3 Mexico
10.3 ASIA-PACIFIC
10.3.1 APAC HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.3.2 Y-O-Y GROWTH TREND ANALYSIS
10.3.2.1 China
10.3.2.2 Japan
10.3.2.3 Korea
10.3.2.4 India
10.3.2.5 Southeast Asia
10.4 MIDDLE EAST AND AFRICA
10.4.1 MIDDLE EAST AND AFRICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.4.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
10.4.3 Y-O-Y GROWTH TREND ANALYSIS
10.4.3.1 Saudi Arabia
10.4.3.2 UAE
10.4.3.3 Egypt
10.4.3.4 Nigeria
10.4.3.5 South Africa
10.5 EUROPE
10.5.1 EUROPE HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.5.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
10.5.3 Y-O-Y GROWTH TREND ANALYSIS
10.5.3.1 Germany
10.5.3.2 France
10.5.3.3 UK
10.5.3.4 Russia
10.5.3.5 Italy
10.6 LATIN AMERICA
10.6.1 LATIN AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.6.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
10.6.3 Y-O-Y GROWTH TREND ANALYSIS
10.6.3.1 Brazil
10.6.3.2 Argentina
10.6.3.3 Columbia
11 MARKET PLAYERS
11.1 AGILENT TECHNOLOGIES, INC
11.1.1 BUSINESS OVERVIEW:
11.1.2 PRODUCT PORTFOLIO
11.1.3 RECENT DEVELOPMENTS
11.1.4 SWOT ANALYSIS:
11.2 BGI GROUP
11.3 F. HOFFMANN-LA ROCHE AG
11.4 ILLUMINA INC
11.5 PRECIGEN INC., (INTREXON BIOINFORMATICS GERMANY GMBH)
11.6 PACIFIC BIOSCIENCES OF CALIFORNIA, INC
11.7 PERKINELMER, INC.
11.8 PIERIANDX INC.
11.9 QIAGEN N.V.
11.10 THERMO FISHER SCIENTIFIC INC.
12 ABOUT US
1.1 OBJECTIVES
1.2 RESEARCH METHODOLOGY
1.2.1 SECONDARY DATA
1.2.2 PRIMARY DATA
1.2.3 MARKET SIZE ESTIMATION
1.2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
1.3 STAKEHOLDERS
1.4 RESEARCH ASSUMPTIONS
1.5 LIMITATION
2 EXECUTIVE SUMMARY
3 MARKET OUTLOOK
3.1 INTRODUCTION
3.2 OPPORTUNITIES MATRIX
3.3 MARKET CHALLENGES
3.4 MARKET SHARE ANALYSIS
3.5 VALUE CHAIN ANALYSIS
3.6 DEMAND SIDE ANALYSIS
3.7 SUPPLY SIDE ANALYSIS
3.8 PORTER’S FIVE FORCES MODEL
3.8.1 DEGREE OF COMPETITION
3.8.2 BARGAINING POWER OF BUYERS
3.8.3 BARGAINING POWER OF SUPPLIERS
3.8.4 THREAT FROM SUBSTITUTES
3.8.5 THREAT FROM NEW ENTRANTS
4 INDUSTRY TRENDS
4.1 PRODUCT LIFE CYCLE
4.2 NEW MARKET ENTRY STRATEGY
4.3 PESTEL ANALYSIS
4.4 PRICING ANALYSIS
4.5 TRADE DATA
4.6 TECHNOLOGICAL OVERVIEW
4.7 FUTURE OUTLOOK MARKET TRENDS
4.8 MACRO-ECONOMIC VARIABLES (DEPENDENT AND INDEPENDENT VARIABLES)
4.9 MULTIFACTOR BASED SENSITIVITY ANALYSIS
4.10 REGRESSION MATRIX
4.11 COVID-19 IMPACT ANALYSES
4.12 GE MATRIX
5 NEXT GENERATION SEQUENCING (NGS) TYPE ANALYSIS
5.1 INTRODUCTION
5.2 HISTORICAL MARKET TYPE ANALYSIS, 2016-2020
5.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
5.4 Y-O-Y GROWTH TREND ANALYSIS
5.5 INSTRUMENTS
5.6 CONSUMABLES
5.6.1 SAMPLE PREPARATION CONSUMABLES
5.6.1.1 DNA Fragmentation, End Repair, A-Tailing and Size Selection
5.6.1.2 Library Preparation & Target Enrichment
5.6.1.3 Quality Control
5.6.2 OTHER CONSUMABLES
5.6.2.1 Platforms
5.6.2.2 HiSeq
5.6.2.3 MiSeq
5.6.2.4 Ion Torrent
5.6.2.5 SOLiD
5.6.2.6 Pacbio Rs II and Sequel System
5.6.2.7 Other Sequencing Platforms
5.7 SERVICES
5.7.1 SEQUENCING SERVICES
5.7.1.1 RNA Sequencing
5.7.1.2 Whole Exome Sequencing
5.7.1.3 Whole Genome Sequencing
5.7.1.4 Targeted Sequencing
5.7.1.5 Chip Sequencing
5.7.1.6 De Novo Sequencing
5.7.1.7 Methyl Sequencing
5.7.2 DATA MANAGEMENT SERVICES
5.7.2.1 NGS Data Analysis Services
5.7.2.2 NGS Data Analysis Software & Workbenches
5.7.2.3 NGS Storage, Management and Cloud Computing Solutions
6 NEXT GENERATION SEQUENCING (NGS) TYPE OF SEQUENCING ANALYSIS
6.1 INTRODUCTION
6.2 HISTORICAL MARKET TYPE OF SEQUENCING ANALYSIS, 2016-2020
6.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
6.4 Y-O-Y GROWTH TREND ANALYSIS
6.5 WHOLE GENOME SEQUENCING
6.6 TARGETED RESEQUENCING
6.7 WHOLE EXOME SEQUENCING
6.8 RNA SEQUENCING
6.9 CHIP SEQUENCING
6.10 DE NOVO SEQUENCING
6.11 METHYL SEQUENCING
7 NEXT GENERATION SEQUENCING (NGS) TECHNOLOGY ANALYSIS
7.1 INTRODUCTION
7.2 HISTORICAL MARKET TECHNOLOGY ANALYSIS, 2016-2020
7.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
7.4 Y-O-Y GROWTH TREND ANALYSIS
7.5 SEQUENCING BY SYNTHESIS
7.6 ION SEMICONDUCTOR SEQUENCING
7.7 SEQUENCING BY LIGATION
7.8 PYROSEQUENCING
7.9 SINGLE MOLECULE REAL TIME SEQUENCING
7.10 OTHER TECHNOLOGIES
8 NEXT GENERATION SEQUENCING (NGS) END USER ANALYSIS
8.1 INTRODUCTION
8.2 HISTORICAL MARKET END USER ANALYSIS, 2016-2020
8.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
8.4 Y-O-Y GROWTH TREND ANALYSIS
8.5 ACADEMIC AND RESEARCH CENTERS
8.6 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
8.7 HOSPITALS AND CLINICS
8.8 OTHER END USERS
9 NEXT GENERATION SEQUENCING (NGS) MARKET APPLICATION ANALYSIS
9.1 INTRODUCTION
9.2 HISTORICAL MARKET APPLICATION ANALYSIS, 2016-2020
9.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
9.4 Y-O-Y GROWTH TREND ANALYSIS
9.5 DIAGNOSTICS
9.6 BIOMARKERS AND CANCER
9.7 REPRODUCTIVE HEALTH
9.8 PERSONALIZED MEDICINE
9.9 AGRICULTURE AND ANIMAL RESEARCH
9.10 OTHER APPLICATIONS
10 GLOBAL NEXT GENERATION SEQUENCING (NGS) REGIONAL ANALYSIS
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 NORTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.2.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
10.2.3 Y-O-Y GROWTH TREND ANALYSIS
10.2.3.1 U.S.
10.2.3.2 Canada
10.2.3.3 Mexico
10.3 ASIA-PACIFIC
10.3.1 APAC HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.3.2 Y-O-Y GROWTH TREND ANALYSIS
10.3.2.1 China
10.3.2.2 Japan
10.3.2.3 Korea
10.3.2.4 India
10.3.2.5 Southeast Asia
10.4 MIDDLE EAST AND AFRICA
10.4.1 MIDDLE EAST AND AFRICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.4.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
10.4.3 Y-O-Y GROWTH TREND ANALYSIS
10.4.3.1 Saudi Arabia
10.4.3.2 UAE
10.4.3.3 Egypt
10.4.3.4 Nigeria
10.4.3.5 South Africa
10.5 EUROPE
10.5.1 EUROPE HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.5.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
10.5.3 Y-O-Y GROWTH TREND ANALYSIS
10.5.3.1 Germany
10.5.3.2 France
10.5.3.3 UK
10.5.3.4 Russia
10.5.3.5 Italy
10.6 LATIN AMERICA
10.6.1 LATIN AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.6.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
10.6.3 Y-O-Y GROWTH TREND ANALYSIS
10.6.3.1 Brazil
10.6.3.2 Argentina
10.6.3.3 Columbia
11 MARKET PLAYERS
11.1 AGILENT TECHNOLOGIES, INC
11.1.1 BUSINESS OVERVIEW:
11.1.2 PRODUCT PORTFOLIO
11.1.3 RECENT DEVELOPMENTS
11.1.4 SWOT ANALYSIS:
11.2 BGI GROUP
11.3 F. HOFFMANN-LA ROCHE AG
11.4 ILLUMINA INC
11.5 PRECIGEN INC., (INTREXON BIOINFORMATICS GERMANY GMBH)
11.6 PACIFIC BIOSCIENCES OF CALIFORNIA, INC
11.7 PERKINELMER, INC.
11.8 PIERIANDX INC.
11.9 QIAGEN N.V.
11.10 THERMO FISHER SCIENTIFIC INC.
12 ABOUT US
TABLE 1 NEXT GENERATION SEQUENCING (NGS) REGIONAL ANALYSIS, 2021–2030 (USD MILLION)
TABLE 2 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, 2021–2030, (USD MILLION)
TABLE 3 NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE REGIONAL ANALYSIS, 2021–2030 (USD MILLION)
TABLE 4 GLOBAL NEXT GENERATION SEQUENCING (NGS) HISTORICAL MARKET TYPE ANALYSIS, 2016-2020, (USD MILLION)
TABLE 5 NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 6 GLOBAL NEXT GENERATION SEQUENCING (NGS) HISTORICAL MARKET TYPE OF SEQUENCING ANALYSIS, 2016-2020, (USD MILLION)
TABLE 7 NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE OF SEQUENCING ANALYSIS, 2021–2030 (USD MILLION)
TABLE 8 GLOBAL NEXT GENERATION SEQUENCING (NGS) HISTORICAL MARKET TECHNOLOGY ANALYSIS, 2016-2020, (USD MILLION)
TABLE 9 NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030 (USD MILLION)
TABLE 10 GLOBAL NEXT GENERATION SEQUENCING (NGS) HISTORICAL MARKET END USER ANALYSIS, 2016-2020, (USD MILLION)
TABLE 11 NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE END USER ANALYSIS, 2021–2030 (USD MILLION)
TABLE 12 GLOBAL NEXT GENERATION SEQUENCING (NGS) HISTORICAL MARKET APPLICATION ANALYSIS, 2016-2020, (USD MILLION)
TABLE 13 NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 14 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 15 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 16 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE OF SEQUENCING ANALYSIS, 2021–2030 (USD MILLION)
TABLE 17 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030 (USD MILLION)
TABLE 18 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE END USER ANALYSIS, 2021–2030 (USD MILLION)
TABLE 19 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 20 U.S. NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2016–2021
TABLE 21 U.S. NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 22 U.S. NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 23 CANADA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 24 CANADA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 25 MEXICO NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 26 MEXICO NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 27 APAC NEXT GENERATION SEQUENCING (NGS) HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 28 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 29 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE OF SEQUENCING ANALYSIS, 2021–2030 (USD MILLION)
TABLE 30 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030 (USD MILLION)
TABLE 31 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE END USER ANALYSIS, 2021–2030 (USD MILLION)
TABLE 32 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 33 CHINA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 34 CHINA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 35 JAPAN NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 36 JAPAN NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 37 KOREA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 38 KOREA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 39 INDIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 40 INDIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 41 SOUTHEAST ASIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 42 SOUTHEAST ASIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 43 MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 44 MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 45 MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE OF SEQUENCING ANALYSIS, 2021–2030 (USD MILLION)
TABLE 46 MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030 (USD MILLION)
TABLE 47 MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE END USER ANALYSIS, 2021–2030 (USD MILLION)
TABLE 48 MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 49 SAUDI ARABIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 50 SAUDI ARABIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 51 UAE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 52 UAE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 53 EGYPT NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 54 EGYPT NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 55 NIGERIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 56 NIGERIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 57 SOUTH AFRICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 58 SOUTH AFRICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 59 EUROPE NEXT GENERATION SEQUENCING (NGS) HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 60 EUROPE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 61 EUROPE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE OF SEQUENCING ANALYSIS, 2021–2030 (USD MILLION)
TABLE 62 EUROPE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030 (USD MILLION)
TABLE 63 EUROPE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE END USER ANALYSIS, 2021–2030 (USD MILLION)
TABLE 64 EUROPE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 65 GERMANY NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 66 GERMANY NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 67 FRANCE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 68 FRANCE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 69 UK NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 70 UK NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 71 RUSSIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 72 RUSSIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 73 ITALY NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 74 ITALY NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 75 LATIN AMERICA NEXT GENERATION SEQUENCING (NGS) HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 76 LATIN AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 77 LATIN AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE OF SEQUENCING ANALYSIS, 2021–2030 (USD MILLION)
TABLE 78 LATIN AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030 (USD MILLION)
TABLE 79 LATIN AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE END USER ANALYSIS, 2021–2030 (USD MILLION)
TABLE 80 LATIN AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 81 BRAZIL NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 82 BRAZIL NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 83 ARGENTINA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 84 ARGENTINA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 85 COLUMBIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 86 COLUMBIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 1 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, 2021–2030, (USD MILLION)
FIGURE 2 RESEARCH METHODOLOGY
FIGURE 3 GLOBAL NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE MARKET, 2021–2030, (USD MILLION)
FIGURE 4 GLOBAL NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE MARKET, 2021–2030, (USD MILLION)
FIGURE 5 MARKET OVERVIEW
FIGURE 6 SWOT ANALYSIS
FIGURE 7 MARKET SHARE ANALYSIS
FIGURE 8 SUPPLY CHAIN ANALYSIS
FIGURE 9 PORTER’S FIVE FORCES ANALYSIS
FIGURE 10 NEXT GENERATION SEQUENCING (NGS) TYPE ANALYSIS
FIGURE 11 GLOBAL NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE MARKET TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 12 NEXT GENERATION SEQUENCING (NGS) TYPE OF SEQUENCING ANALYSIS
FIGURE 13 GLOBAL NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE MARKET TYPE OF SEQUENCING ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 14 NEXT GENERATION SEQUENCING (NGS) TECHNOLOGY ANALYSIS
FIGURE 15 GLOBAL NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE MARKET TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 16 NEXT GENERATION SEQUENCING (NGS) END USER ANALYSIS
FIGURE 17 GLOBAL NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE MARKET END USER ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 18 NEXT GENERATION SEQUENCING (NGS) APPLICATION ANALYSIS
FIGURE 19 GLOBAL NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE MARKET APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 20 GLOBAL NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE MARKET VOLUME SHARE REGIONAL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 21 MARKET OVERVIEW, REGIONAL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 22 MARKET SHARE BY COUNTRY
FIGURE 23 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 24 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE OF SEQUENCING ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 25 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 26 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE END USER ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 27 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 28 U.S. NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 29 U.S. NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 30 CANADA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 31 CANADA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 32 MEXICO NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 33 MEXICO NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 34 MARKET SHARE BY COUNTRY
FIGURE 35 APAC NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 36 APAC NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE OF SEQUENCING ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 37 APAC NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 38 APAC NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE END USER ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 39 APAC NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 40 CHINA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 41 CHINA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 42 JAPAN NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 43 JAPAN NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 44 KOREA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 45 KOREA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 46 INDIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 47 INDIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 48 SOUTHEAST ASIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 49 SOUTHEAST ASIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 50 MARKET SHARE BY COUNTRY
FIGURE 51 MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 52 MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE OF SEQUENCING ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 53 MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 54 MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE END USER ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 55 MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 56 SAUDI ARABIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 57 SAUDI ARABIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 58 UAE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 59 UAE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 60 EGYPT NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 61 EGYPT NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 62 NIGERIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 63 NIGERIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 64 SOUTH AFRICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 65 SOUTH AFRICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 66 MARKET SHARE BY COUNTRY
FIGURE 67 EUROPE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 68 EUROPE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE OF SEQUENCING ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 69 EUROPE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 70 EUROPE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE END USER ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 71 EUROPE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 72 GERMANY NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 73 GERMANY NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 74 FRANCE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 75 FRANCE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 76 UK NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 77 UK NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 78 RUSSIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 79 RUSSIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 80 ITALY NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 81 ITALY NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 82 MARKET SHARE BY COUNTRY
FIGURE 83 LATIN AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 84 LATIN AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE OF SEQUENCING ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 85 LATIN AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 86 LATIN AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE END USER ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 87 LATIN AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 88 BRAZIL NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 89 BRAZIL NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 90 ARGENTINA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 91 ARGENTINA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 92 COLUMBIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 93 COLUMBIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 94 FINANCIAL OVERVIEW:
TABLE 2 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, 2021–2030, (USD MILLION)
TABLE 3 NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE REGIONAL ANALYSIS, 2021–2030 (USD MILLION)
TABLE 4 GLOBAL NEXT GENERATION SEQUENCING (NGS) HISTORICAL MARKET TYPE ANALYSIS, 2016-2020, (USD MILLION)
TABLE 5 NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 6 GLOBAL NEXT GENERATION SEQUENCING (NGS) HISTORICAL MARKET TYPE OF SEQUENCING ANALYSIS, 2016-2020, (USD MILLION)
TABLE 7 NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE OF SEQUENCING ANALYSIS, 2021–2030 (USD MILLION)
TABLE 8 GLOBAL NEXT GENERATION SEQUENCING (NGS) HISTORICAL MARKET TECHNOLOGY ANALYSIS, 2016-2020, (USD MILLION)
TABLE 9 NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030 (USD MILLION)
TABLE 10 GLOBAL NEXT GENERATION SEQUENCING (NGS) HISTORICAL MARKET END USER ANALYSIS, 2016-2020, (USD MILLION)
TABLE 11 NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE END USER ANALYSIS, 2021–2030 (USD MILLION)
TABLE 12 GLOBAL NEXT GENERATION SEQUENCING (NGS) HISTORICAL MARKET APPLICATION ANALYSIS, 2016-2020, (USD MILLION)
TABLE 13 NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 14 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 15 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 16 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE OF SEQUENCING ANALYSIS, 2021–2030 (USD MILLION)
TABLE 17 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030 (USD MILLION)
TABLE 18 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE END USER ANALYSIS, 2021–2030 (USD MILLION)
TABLE 19 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 20 U.S. NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2016–2021
TABLE 21 U.S. NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 22 U.S. NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 23 CANADA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 24 CANADA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 25 MEXICO NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 26 MEXICO NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 27 APAC NEXT GENERATION SEQUENCING (NGS) HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 28 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 29 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE OF SEQUENCING ANALYSIS, 2021–2030 (USD MILLION)
TABLE 30 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030 (USD MILLION)
TABLE 31 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE END USER ANALYSIS, 2021–2030 (USD MILLION)
TABLE 32 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 33 CHINA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 34 CHINA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 35 JAPAN NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 36 JAPAN NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 37 KOREA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 38 KOREA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 39 INDIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 40 INDIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 41 SOUTHEAST ASIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 42 SOUTHEAST ASIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 43 MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 44 MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 45 MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE OF SEQUENCING ANALYSIS, 2021–2030 (USD MILLION)
TABLE 46 MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030 (USD MILLION)
TABLE 47 MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE END USER ANALYSIS, 2021–2030 (USD MILLION)
TABLE 48 MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 49 SAUDI ARABIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 50 SAUDI ARABIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 51 UAE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 52 UAE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 53 EGYPT NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 54 EGYPT NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 55 NIGERIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 56 NIGERIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 57 SOUTH AFRICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 58 SOUTH AFRICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 59 EUROPE NEXT GENERATION SEQUENCING (NGS) HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 60 EUROPE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 61 EUROPE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE OF SEQUENCING ANALYSIS, 2021–2030 (USD MILLION)
TABLE 62 EUROPE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030 (USD MILLION)
TABLE 63 EUROPE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE END USER ANALYSIS, 2021–2030 (USD MILLION)
TABLE 64 EUROPE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 65 GERMANY NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 66 GERMANY NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 67 FRANCE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 68 FRANCE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 69 UK NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 70 UK NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 71 RUSSIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 72 RUSSIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 73 ITALY NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 74 ITALY NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 75 LATIN AMERICA NEXT GENERATION SEQUENCING (NGS) HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 76 LATIN AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 77 LATIN AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE OF SEQUENCING ANALYSIS, 2021–2030 (USD MILLION)
TABLE 78 LATIN AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030 (USD MILLION)
TABLE 79 LATIN AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE END USER ANALYSIS, 2021–2030 (USD MILLION)
TABLE 80 LATIN AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 81 BRAZIL NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 82 BRAZIL NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 83 ARGENTINA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 84 ARGENTINA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 85 COLUMBIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 86 COLUMBIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 1 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, 2021–2030, (USD MILLION)
FIGURE 2 RESEARCH METHODOLOGY
FIGURE 3 GLOBAL NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE MARKET, 2021–2030, (USD MILLION)
FIGURE 4 GLOBAL NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE MARKET, 2021–2030, (USD MILLION)
FIGURE 5 MARKET OVERVIEW
FIGURE 6 SWOT ANALYSIS
FIGURE 7 MARKET SHARE ANALYSIS
FIGURE 8 SUPPLY CHAIN ANALYSIS
FIGURE 9 PORTER’S FIVE FORCES ANALYSIS
FIGURE 10 NEXT GENERATION SEQUENCING (NGS) TYPE ANALYSIS
FIGURE 11 GLOBAL NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE MARKET TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 12 NEXT GENERATION SEQUENCING (NGS) TYPE OF SEQUENCING ANALYSIS
FIGURE 13 GLOBAL NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE MARKET TYPE OF SEQUENCING ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 14 NEXT GENERATION SEQUENCING (NGS) TECHNOLOGY ANALYSIS
FIGURE 15 GLOBAL NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE MARKET TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 16 NEXT GENERATION SEQUENCING (NGS) END USER ANALYSIS
FIGURE 17 GLOBAL NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE MARKET END USER ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 18 NEXT GENERATION SEQUENCING (NGS) APPLICATION ANALYSIS
FIGURE 19 GLOBAL NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE MARKET APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 20 GLOBAL NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE MARKET VOLUME SHARE REGIONAL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 21 MARKET OVERVIEW, REGIONAL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 22 MARKET SHARE BY COUNTRY
FIGURE 23 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 24 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE OF SEQUENCING ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 25 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 26 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE END USER ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 27 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 28 U.S. NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 29 U.S. NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 30 CANADA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 31 CANADA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 32 MEXICO NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 33 MEXICO NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 34 MARKET SHARE BY COUNTRY
FIGURE 35 APAC NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 36 APAC NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE OF SEQUENCING ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 37 APAC NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 38 APAC NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE END USER ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 39 APAC NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 40 CHINA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 41 CHINA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 42 JAPAN NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 43 JAPAN NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 44 KOREA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 45 KOREA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 46 INDIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 47 INDIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 48 SOUTHEAST ASIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 49 SOUTHEAST ASIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 50 MARKET SHARE BY COUNTRY
FIGURE 51 MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 52 MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE OF SEQUENCING ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 53 MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 54 MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE END USER ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 55 MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 56 SAUDI ARABIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 57 SAUDI ARABIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 58 UAE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 59 UAE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 60 EGYPT NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 61 EGYPT NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 62 NIGERIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 63 NIGERIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 64 SOUTH AFRICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 65 SOUTH AFRICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 66 MARKET SHARE BY COUNTRY
FIGURE 67 EUROPE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 68 EUROPE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE OF SEQUENCING ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 69 EUROPE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 70 EUROPE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE END USER ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 71 EUROPE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 72 GERMANY NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 73 GERMANY NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 74 FRANCE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 75 FRANCE NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 76 UK NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 77 UK NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 78 RUSSIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 79 RUSSIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 80 ITALY NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 81 ITALY NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 82 MARKET SHARE BY COUNTRY
FIGURE 83 LATIN AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 84 LATIN AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE OF SEQUENCING ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 85 LATIN AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 86 LATIN AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE END USER ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 87 LATIN AMERICA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 88 BRAZIL NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 89 BRAZIL NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 90 ARGENTINA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 91 ARGENTINA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 92 COLUMBIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 93 COLUMBIA NEXT GENERATION SEQUENCING (NGS) CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 94 FINANCIAL OVERVIEW:
FAQ
Premium Report Details
Published On:5-Feb-22
Base Year:2024
Historical Data:2019
No of Pages:170
Buy Now
Need a Discount? Get in touch with us for special pricing
Connect with our sales team
Global Next Generation Sequencing (NGS) Market- In...
RD Code : HP22Subscribe Us
Sign up today for tips and latest news
and exclusive special offers.
